Bergamo Lymphoid Cancer Registry
Recruiting
Observational Study
Hodgkin Lymphoma
Non Hodgkin Lymphoma
Myeloma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 6,000 (estimated)
- Sponsor
- A.O. Ospedale Papa Giovanni XXIII · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This registry has been established to gain a better understanding of the clinical and biological characteristics and outcome of patients with lymphoid cancer
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male or female patients 18 years or older
* Written informed consent
* Confirmed diagnosis of Hodgkin disease, non-Hodgkin lymphomas or myeloma
Exclusion Criteria:
\- Unconfirmed diagnosis of Hodgkin disease, non-Hodgkin lymphomas or myeloma
Contacts